Bioxyne Limited (AU:BXN) has released an update.
Bioxyne Limited has issued 2,583,334 shares to its employees at $0.01 each under the Employee Incentive Plan, enhancing its commitment to employee engagement and growth. This strategic move aligns with their focus on expanding their health and wellness product offerings internationally through their subsidiary, Breathe Life Sciences, which operates in several global markets including the UK, Europe, and Japan.
For further insights into AU:BXN stock, check out TipRanks’ Stock Analysis page.